IBCCES is the global leader in training and certification for healthcare professionals, educators and corporate partners who work with individuals with autism and other cognitive disorders. Our reach extends to more than 2 million people in all 50 states and over 70 countries around the globe. IBCCES Member Learning Community is provided as a free service to all IBCCES members who have completed one or more of our training and certification programs.
Protecting brain cells with cannabinol
Scientists created four cannabis-derived CBN analogs (chemical look-a-likes) with enhanced neuroprotective properties and potential for therapeutic application in neurological disorders like Alzheimer’s, Parkinson’s, and traumatic brain injury. Their findings reveal novel aspects of CBN’s neuroprotective activity and demonstrate the clinical potential of CBN and value of studying its analogs.